EnviroTechnologies International Inc. (ETII)

[bluesky2]

In lieu of old_schooler's response, here are a few comments of my own that in part addresses your concerns:

In November 2010 Mr Grofe apparently moved on with the MedBioWeb Corp sale. See…

http://stocktalknews.com/1962/healthnostics-sells-medbioweb-corp-for-2-million-2/

------------------

Partial 2/24/11 Healthnostics Staff response to a message board request (similar to your own):

2. HNSS, like other Pink Sheet companies, is not a reporting company. Reporting entails substantial legal, accounting, and managerial costs that small, growing companies can better spend in profit-producing endeavors. 

3. Management strives to provide information to investors that does not compromise its competitive business positions. Further, growing companies face changing environments and circumstances, which is why periodic reports, instead of continuous reports, are issued. 

4. Management spends its time operating and building the Company, and it cannot devote substantial time advising callers that they cannot say to one what they have not said to all. Therefore, limited written responses that comply with regulations are the preferred means of communication. 

5. Outstanding share numbers regularly change due to repurchases, weighted averaging, acquisitions, etc. And the float changes even more rapidly as shares move from speculative to investment hands. As a result, management can only address the outstanding share issue on a limited periodic basis. 

Further, it is important for investors to concentrate on the fundamentals. Management is building a company and has provided investors with information to ward that end. Management does not concentrate on short term stock price fluctuations or the continuous flow of information that would drive them. 

Healthnostics Staff

------------------

FrankLind: In my view HNSS at this stage in the game will be rather tightfisted with regard to providing details on "competitive advantage" and related. After all, they're a Pink Sheet reporting entity and most likely from experience have learned to closely guard product and market development, as well as related financing, from prying eyes. However, you have asked THE key question. There are many postings on this board related to that concern. Here is a summary response from 2/8/11 that might interest you:

All the pieces that have been put in place lead me to believe that this is about as good as you can get in a pink without knowing the full details. 

1) Company bought back 65%+ of it shares in less than 8 months. 

2) CEO owns 25 million+ shares 

3) Profits, Revenues and Assets are Increasing 

4) Debt is decreasing 

5) Product lines are being further developed 

6) Business is expanding to Europe 

7) Many companies are interested in HNSS's technology 

8) Zero dilution 

9) Share reduction...

Hope the above helps a little. THX for your interest. We really and truly want longs onboard. We believe the HNSS opportunity is unique and well worth the time and energy necessary to see thru the short term challenges...